Overview
Updated 14 Jul 2026
Richard A. Lafayette, MD, is Professor of Medicine (Nephrology) at Stanford University School of Medicine. The public record shows 306 publications with 10,765 citations (h-index 51), centered on Nephrology. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 23 companies, 1 NIH-funded awards (2000–2001).
- Most recent indexed publication: 2026 · Clinical journal of the American Society of Nephrology
- Top research focus: Nephrology
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Sponsor: Stanford University
InvestigatorPhase 4CompletedNCT01155141
Industry payments
Updated 14 Jul 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202520 payments$30,404openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year202517 payments$20,055openpaymentsdata.cms.gov ↗
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year202516 payments$19,477openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2000–2001 per NIH RePORTER. The latest:
- ORAL CALCIMIMETIC AGENT IN SECONDARY HYPERPARATHYROIDISM
Stanford University
FY2001$134,676M01RR000070
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial.
Clinical journal of the American Society of Nephrology
2026 - A plain language summary: long-term safety and effectiveness of atacicept in individuals with IgA nephropathy.
Current medical research and opinion
2025 - TESTING for the Best Biomarker in IgA Nephropathy.
Clinical journal of the American Society of Nephrology
2025 - Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?
Journal of the American Society of Nephrology
2025
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
300 Pasteur Dr Ste A175, MC 5309, Stanford, CA 94305
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.stanford.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.stanford.edu ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- Founder and Director
Stanford Glomerular Disease Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Media & interviewspress, podcasts and appearances
- ASN Podcast: "Kidney Week 2025 - Late-Breaking Clinical Trials" panel with Julie R. Ingelfinger
MD and Hiddo Jan L. Heerspink, PhD …
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →threads.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/richard-lafayette-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
medicine.stanford.edu/news/current-news/standard-news/lafayette-named-chief-editor.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.stanford.edu ↗ - X / Twitter
x.com/asnkidney
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Vibeke Strand, MD
Stanford University School of Medicine
- 784
- publications
- 94
- h-index
- 1
- trial
Paul Kwo, MD
Stanford University School of Medicine
- 473
- publications
- 67
- h-index
- 2
- trials
Philip Sager, MD
Stanford University School of Medicine
- 192
- publications
- 48
- h-index
- 1
- trial
Michael Ostacher, MD
Stanford University School of Medicine
- 182
- publications
- 50
- h-index
- 2
- trials